XML 18 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
At Market Issuance Sales Agreement
Common Stock
Common Stock
At Market Issuance Sales Agreement
Additional Paid-in Capital
Additional Paid-in Capital
At Market Issuance Sales Agreement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024     116,934,314          
Beginning balance at Dec. 31, 2024 $ 69,472   $ 12   $ 243,794   $ 0 $ (174,334)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost (in shares)       2,585,646        
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost   $ 8,429       $ 8,429    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     1,026,117          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 48       48      
Stock-based compensation 1,822       1,822      
Net loss (9,371)             (9,371)
Other comprehensive income (loss) (4)           (4)  
Ending balance (in shares) at Mar. 31, 2025     120,546,077          
Ending balance at Mar. 31, 2025 70,396   $ 12   254,093   (4) (183,705)
Beginning balance (in shares) at Dec. 31, 2024     116,934,314          
Beginning balance at Dec. 31, 2024 69,472   $ 12   243,794   0 (174,334)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (15,741)              
Ending balance (in shares) at Jun. 30, 2025     125,075,837          
Ending balance at Jun. 30, 2025 76,654   $ 13   266,723   (7) (190,075)
Beginning balance (in shares) at Mar. 31, 2025     120,546,077          
Beginning balance at Mar. 31, 2025 70,396   $ 12   254,093   (4) (183,705)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost (in shares)       3,175,850        
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost   9,707   $ 1   9,706    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     1,353,910          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 1,018       1,018      
Stock-based compensation 1,906       1,906      
Net loss (6,370)             (6,370)
Other comprehensive income (loss) (3)           (3)  
Ending balance (in shares) at Jun. 30, 2025     125,075,837          
Ending balance at Jun. 30, 2025 $ 76,654   $ 13   266,723   (7) (190,075)
Beginning balance (in shares) at Dec. 31, 2025 134,536,592   134,536,592          
Beginning balance at Dec. 31, 2025 $ 103,815   $ 13   322,156   4 (218,358)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     4,557,105          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 6,686       6,686      
Issuance of common stock upon exchange of stock warrants for shares of common stock (in shares)     190,364          
Issuance of common stock upon exchange of stock warrants for shares of common stock 1,895       1,895      
Stock-based compensation 2,058       2,058      
Net loss (5,046)             (5,046)
Other comprehensive income (loss) 6           6  
Ending balance (in shares) at Mar. 31, 2026     139,284,061          
Ending balance at Mar. 31, 2026 $ 109,414   $ 13   332,795   10 (223,404)
Beginning balance (in shares) at Dec. 31, 2025 134,536,592   134,536,592          
Beginning balance at Dec. 31, 2025 $ 103,815   $ 13   322,156   4 (218,358)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss $ (8,200)              
Ending balance (in shares) at Jun. 30, 2026 146,080,618   146,080,618          
Ending balance at Jun. 30, 2026 $ 125,636   $ 14   352,157   23 (226,558)
Beginning balance (in shares) at Mar. 31, 2026     139,284,061          
Beginning balance at Mar. 31, 2026 109,414   $ 13   332,795   10 (223,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)       3,081,191        
Issuance of common stock upon exercise of stock options and vesting of restricted stock units   $ 4,535   $ 1   $ 4,534    
Issuance of common stock upon exchange of stock warrants for shares of common stock (in shares)     3,715,366          
Issuance of common stock upon exchange of stock warrants for shares of common stock 12,287       12,287      
Stock-based compensation 2,541       2,541      
Net loss (3,154)             (3,154)
Other comprehensive income (loss) $ 13           13  
Ending balance (in shares) at Jun. 30, 2026 146,080,618   146,080,618          
Ending balance at Jun. 30, 2026 $ 125,636   $ 14   $ 352,157   $ 23 $ (226,558)